Ophthalmologica

VOL: 243 ISSUE: 4

Ophthalmologica
Sebastian Wolf
Published: Thursday, July 30, 2020
EYES WITH DME FARE BETTER WITH RANIBIZUMAB IN RANDOMISED CONTROLLED TRIALS THAN IN REAL-WORLD STUDIES A meta-analysis of 29 randomised controlled trials (RCTs) and 11 real-world studies shows that the improvements in BCVA diabetic macular oedema (DME) patients achieve over three years of treatment with ranibizumab correlates strongly with the number of the injections they receive. The analysis showed an increase in BCVA of 8.2, 9.4 and 10.3 ETDRS from baseline following 12, 24 and 36 months, respectively, of ranibizumab treatment. The largest changes in BCVA at 12 months were observed in RCTs and the smallest in real-world studies. In addition, an increase of one injection was associated with an increase in BCVA of 0.6 letters at 12 months. M Falcão et al “Impact of Intravitreal Ranibizumab Therapy on Vision Outcomes in Diabetic Macular Edema Patients: A Meta-Analysis”, Ophthalmologica 2020, Volume 243, issue 4 OCT-A PROVIDES WINDOW TO THE KIDNEY OF DIABETIC PATIENTS Evaluation of retinal microcirculation with optical coherence tomography angiography (OCT-A) can detect early changes related to nephropathy in type 2 diabetic patients, a new study indicates. It showed that, compared with 42 normoalbuminuric diabetic patients without retinopathy and 55 controls , 42 diabetic patients with microalbuminuria had significantly decreased mean vessel densities of the superficial capillary plexus (SCP), whole disc, and peripapillary area (p<0.05 for all). Both duration of diabetes and urinary albumin levels were significantly and moderately correlated with mean vessel density of whole SCP in diabetic patients. V Cankurtaran et. al. “Retinal Microcirculation in Predicting Diabetic Nephropathy in Type 2 Diabetic Patients without Retinopathy”, Ophthalmologica 2020, Volume 243, issue 4. SCLERAL BUCKLING WITH SMALL-GAUGE ENDO-ILLUMINATION PLUS HYALURONATE A new study’s findings indicate that 25-gauge endo-illuminationaided scleral buckling (SB) combined with hyaluronate injection is a safe and effective treatment for rhegmatogenous retinal detachment (RRD). The retrospective study involved 45 RRD patients, 25 of whom underwent the new SB procedure, and 20 of whom underwent conventional SB with binocular indirect ophthalmoscope combined with air injection. The final reattachment rate was 100% in both groups. The improvements of BCVA of the treatment group and control group were –0.49 and –0.42 logMAR, respectively with no significant difference (p=0.594). However, the mean operation duration of the treatment group was significantly shorter than that of the control group (50.19min vs 42.06min, p=0.042). T Zhao et al, “Endo-Illumination-Aided Scleral Buckling Combined with Intravitreal Injection of Hyaluronate for Treatment of Rhegmatogenous Retinal Detachment”, Ophthalmologica 2020, Volume 243, issue 4. Ophthalmologica is the peer-reviewed journal of EURETINA
Tags: Ophthalmologica
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...